Dutch research found that not only are stress sensors inaccurate, but they sometimes report the opposite of user experiences.
New Study Shows Smartwatch Stress Sensors Have No Idea What They’re Doing
Related Posts
Gas Stove Won’t Light? Try These Solutions
Gas stoves sometimes refuse to light but don’t worry, there are several fixes you can try before calling for repairs.
Venture firm CRV raises $750M, downsizing after returning capital to investors
CRV has secured $750 million toward the 55-year-old venture firm’s twentieth flagship fund, it announced on Friday.
The new fund is smaller than the $1 billion early-stage fund CRV closed in the fall of 2022. At that time, the firm also announced a $500 million second Select fund, a capital pool for backing late-stage rounds of existing portfolio companies.
It’s no surprise that CRV is not raising a late-stage fund as part of its new fundraise. Last year, the firm told The New York Times it was returning $275 million from its $500 million Select fund to investors. The firm explained that it would not be raising another late-stage vehicle because follow-on rounds for many of its companies would lower its overall returns.
CRV’s limited partners were eager to back the firm’s smaller fund, the firm said. It raised its entire $750 million fund in just four weeks, with demand for double that amount, CRV wrote.
The latest fund will be used to invest in seed and Series A startups and it will focus on backing consumer and devtools companies.
CRV is known for leading DoorDash’s seed financing and the Series A rounds for both Mercury and Vercel, a cloud platform for web developers, which was last valued at $3.25 billion.
Since its founding in 1970, CRV has backed over 750 startups, with 80 of them eventually going public.
Techcrunch event
San Francisco
|
October 27-29, 2025
The firm’s latest investments include CodeRabbit, a startup for AI code review, and Outtake, a company that uses AI for cybersecurity.
NOBS Toothpaste Tablets: What Dentists Say About Its Main Ingredient
These are the benefits and side effects of viral nano-hydroxyapatite toothpastes like NOBS, as well as why dentists recommend trying the fluoride-free alternative.